Radiomics combined with clinical characteristics predicted the progression-free survival time in first-line targeted therapy for advanced non-small cell lung cancer with EGFR mutat...

por Zhu, Jian-man, Sun, Lei, Wang, Linjing, Zhou, Tong-Chong, Yuan, Yawei, Zhen, Xin, Liao, Zhi-Wei
Publicado 2022